https://www.selleckchem.com/pr....oducts/yap-tead-inhi
g with ALI of unclear etiology, the presence of an underlying cancer should be considered. 50%. For patients presenting with ALI of unclear etiology, the presence of an underlying cancer should be considered. Patients with critical limb-threatening ischemia (CLTI) have had poor long-term survival after lower extremity revascularization owing to coexistent coronary artery disease. A new cardiac diagnostic test, coronary computed tomography-derived fractional flow reserve (FFR ), can identify patients with ischemia